Patient Assistance Programs Archives

FDA approves ViiV’s Cabenuva as first complete long-acting regimen for HIV treatment

Adults, Antiretrovirals, Approvals, Clinical Trials, FDA, First-In-Class, GlaxoSmithKline, HIV-1, New Drug Applications, Patient Assistance Programs, R&D, Therapeutics

The U.S. Food and Drug Administration approved ViiV Healthcare’s Cabenuva as the only complete long-acting regimen for the treatment of HIV-1 infection in adults.

January 21, 2021/by Andrew Humphreys